4.6 Article

Benzophenone Derivatives with Histamine H3 Receptor Affinity and Cholinesterase Inhibitory Potency as Multitarget-Directed Ligands for Possible Therapy of Alzheimer's Disease

Related references

Note: Only part of the references are listed.
Review Biochemistry & Molecular Biology

Recent Advances in Virtual Screening for Cholinesterase Inhibitors

Jared A. Miles et al.

Summary: Virtual screening techniques, such as LBVS and SBVS, have emerged as powerful tools for drug discovery in Alzheimer’s disease (AD). Cholinesterases, well-suited for virtual screening, have been the target of numerous studies utilizing these techniques to discover novel inhibitors. Confirmation of the in vitro activity of screening compounds is highlighted as a crucial step in the drug discovery process.

ACS CHEMICAL NEUROSCIENCE (2021)

Article Chemistry, Medicinal

Development and crystallography-aided SAR studies of multifunctional BuChE inhibitors and 5-HT6R antagonists with β-amyloid anti-aggregation properties

Tomasz Wichur et al.

Summary: The lack of effective treatment makes Alzheimer's disease a serious healthcare problem, but the novel multifunctional ligand 50 shows promise as a candidate for effective anti-AD therapy and provides a solid foundation for further research.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)

Review Biochemistry & Molecular Biology

Histamine H3 receptor and cholinesterases as synergistic targets for cognitive decline: Strategies to the rational design of multitarget ligands

Flavia B. Lopes et al.

Summary: The paper reviews the strategies used to obtain dual H3R/ChEs ligands using multitarget design approaches, which includes linking tacrine or flavonoid motifs to H3R antagonists and merging the H3R antagonist pharmacophore with known anticholinesterase molecules. Key modifications in the lipophilic region and use of longer linker groups were suggested to be effective strategies in obtaining novel compounds with high affinity for both targets. Consideration of pharmacokinetic and toxicity profile is important when designing further compounds with improved pharmacological profile.

CHEMICAL BIOLOGY & DRUG DESIGN (2021)

Review Chemistry, Medicinal

Multitarget Directed Ligand Approaches for Alzheimer's Disease: A Comprehensive Review

Natarajan Ramalakshmi et al.

Summary: Alzheimer's disease is a multifactorial neurodegenerative disease without a cure, leading researchers to develop multi-target drugs. Current treatments are palliative and an effective drug for AD is still in the process of discovery.

MINI-REVIEWS IN MEDICINAL CHEMISTRY (2021)

Article Biochemistry & Molecular Biology

Cyanobiphenyls: Novel H3 receptor ligands with cholinesterase and MAO B inhibitory activity as multitarget compounds for potential treatment of Alzheimer's disease

Justyna Godyn et al.

Summary: Alzheimer's disease is a complex and incurable illness that requires urgent approval of new effective drugs. Recent research has shown promising biological activity of compounds designed through a multitarget-directed approach, especially compound 5, which exhibited potential inhibitory effects on multiple targets involved in AD pathophysiology.

BIOORGANIC CHEMISTRY (2021)

Article Biochemistry & Molecular Biology

Biphenylalkoxyamine Derivatives-Histamine H3 Receptor Ligands with Butyrylcholinesterase Inhibitory Activity

Dorota Lazewska et al.

Summary: This study found that certain H3R ligands, which influence neurotransmitter release, can effectively inhibit cholinesterases, providing a promising approach for treating AD.

MOLECULES (2021)

Article Biochemistry & Molecular Biology

In silico and in vitro studies of two non-imidazole multiple targeting agents at histamine H3 receptors and cholinesterase enzymes

Nakisa Ghamari et al.

CHEMICAL BIOLOGY & DRUG DESIGN (2020)

Article Neurosciences

Salsolinol-neurotoxic or Neuroprotective?

Magdalena Kurnik-Lucka et al.

NEUROTOXICITY RESEARCH (2020)

Article Chemistry, Medicinal

Design, synthesis and anti-Alzheimer's disease activity study of xanthone derivatives based on multi-target strategy

Xiaodi Kou et al.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2020)

Article Chemistry, Medicinal

Search for new multi-target compounds against Alzheimer's disease among histamine H-3 receptor ligands

Marek Bajda et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)

Review Biotechnology & Applied Microbiology

Multitarget Therapeutic Strategies for Alzheimer's Disease: Review on Emerging Target Combinations

Samuele Maramai et al.

BIOMED RESEARCH INTERNATIONAL (2020)

Article Chemistry, Medicinal

Rational design of new multitarget histamine H3 receptor ligands as potential candidates for treatment of Alzheimer's disease

Dorota Lazewska et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)

Review Pharmacology & Pharmacy

THE CONNECTION BETWEEN DIFFERENT NEUROTRANSMITTERS INVOLVED IN COGNITIVE PROCESSES

Claudia Handra et al.

FARMACIA (2019)

Article Chemistry, Medicinal

Synthesis and biological activity of novel tert-butyl and tert-pentylphenoxyalkyl piperazine derivatives as histamine H3R ligands

Katarzyna Szczepanska et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)

Article Biochemistry & Molecular Biology

Studies on Anticonvulsant Effects of Novel Histamine H3R Antagonists in Electrically and Chemically Induced Seizures in Rats

Alaa Alachkar et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)

Article Pharmacology & Pharmacy

Formalin injection produces long-lasting hypersensitivity with characteristics of neuropathic pain

Ana Belen Salinas-Abarca et al.

EUROPEAN JOURNAL OF PHARMACOLOGY (2017)

Article Chemistry, Medicinal

Dual/multitargeted xanthone derivatives for Alzheimer's disease: where do we stand?

Maria I. Cruz et al.

FUTURE MEDICINAL CHEMISTRY (2017)

Review Neurosciences

Preclinical Assessment of Inflammatory Pain

Milind M. Muley et al.

CNS NEUROSCIENCE & THERAPEUTICS (2016)

Review Behavioral Sciences

Histamine H3 receptor as a potential target for cognitive symptoms in neuropsychiatric diseases

Bassem Sadek et al.

BEHAVIOURAL BRAIN RESEARCH (2016)

Article Chemistry, Medicinal

Cholinesterase inhibitory activity of chlorophenoxy derivatives-Histamine H3 receptor ligands

Dorota Lazewska et al.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2016)

Review Pharmacology & Pharmacy

Old and new acetylcholinesterase inhibitors for Alzheimer's disease

Daniela Galimberti et al.

EXPERT OPINION ON INVESTIGATIONAL DRUGS (2016)

Review Neurosciences

Neuronal histamine and cognitive symptoms in Alzheimer's disease

Armin Zlomuzica et al.

NEUROPHARMACOLOGY (2016)

Review Neurosciences

Multiple Targeting Approaches on Histamine H3 Receptor Antagonists

Mohammad A. Khanfar et al.

FRONTIERS IN NEUROSCIENCE (2016)

Review Chemistry, Medicinal

New developments around histamine H-3 receptor antagonists/inverse agonists: a patent review (2010-present)

Dorota Lazewska et al.

EXPERT OPINION ON THERAPEUTIC PATENTS (2014)

Article Biochemistry & Molecular Biology

Structure-Based Search for New Inhibitors of Cholinesterases

Marek Bajda et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)

Article Chemistry, Medicinal

Histamine H3 Receptor Function and Ligands: Recent Developments

Mahaveer Singh et al.

MINI-REVIEWS IN MEDICINAL CHEMISTRY (2013)

Review Engineering, Biomedical

CHOLINESTERASES, A TARGET OF PHARMACOLOGY AND TOXICOLOGY

Miroslav Pohanka

BIOMEDICAL PAPERS-OLOMOUC (2011)

Article Chemistry, Medicinal

Multitarget-Directed Ligands: Innovative Chemical Probes and Therapeutic Tools Against Alzheimer's Disease

Maria Laura Bolognesi et al.

CURRENT TOPICS IN MEDICINAL CHEMISTRY (2011)

Article Pharmacology & Pharmacy

Discovery of Histamine H-3 Antagonists for the Treatment of Cognitive Disorders and Alzheimer's Disease

Jorge D. Brioni et al.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2011)

Article Chemistry, Medicinal

Acidic elements in histamine H3 receptor antagonists

Kerstin Sander et al.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)

Article Biochemistry & Molecular Biology

Cholinesterase inhibitors and memory

Giancarlo Pepeu et al.

CHEMICO-BIOLOGICAL INTERACTIONS (2010)

Review Behavioral Sciences

The role of histamine on cognition

Edgardo O. Alvarez

BEHAVIOURAL BRAIN RESEARCH (2009)

Article Chemistry, Medicinal

Design, synthesis, and evaluation of benzophenone derivatives as novel acetylcholinesterase inhibitors

Federica Belluti et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2009)

Article Biochemistry & Molecular Biology

Lead identification of acetylcholinesterase inhibitors-histamine H3 receptor antagonists from molecular modeling

Scott D. Bembenek et al.

BIOORGANIC & MEDICINAL CHEMISTRY (2008)

Article Chemistry, Multidisciplinary

A novel design of artificial membrane for improving the PAMPA model

Xiaoxi Chen et al.

PHARMACEUTICAL RESEARCH (2008)

Article Pharmacology & Pharmacy

Cholinesterase inhibitors: new roles and therapeutic alternatives

E Giacobini

PHARMACOLOGICAL RESEARCH (2004)